dual-drug maintenance
Showing 26 - 50 of >10,000
High Ischemic Risk Trial in Seoul (Ticagrelor-based dual-antiplatelet therapy, Clopidogrel-based dual-antiplatelet therapy)
Not yet recruiting
- High Ischemic Risk
- Ticagrelor-based dual-antiplatelet therapy
- Clopidogrel-based dual-antiplatelet therapy
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Aug 3, 2021
Phenotypic Factors That Predict Success for Weight Loss and
Recruiting
- Obesity
- phenotyping
-
Ann Arbor, MichiganUniversity of Michigan
Aug 18, 2022
Opiate Addiction Trial in France (urine drug testing, no test)
Completed
- Opiate Addiction
- urine drug testing
- no test
-
Clermont-Ferrand, France
- +4 more
Feb 28, 2022
Opioid-use Disorder, Sleep Trial in Detroit (Suvorexant, Suvorexant Placebo)
Recruiting
- Opioid-use Disorder
- Sleep
- Suvorexant
- Suvorexant Placebo
-
Detroit, MichiganWayne State University
Sep 8, 2021
Hearing Loss, Sudden, Hearing Loss, Ototoxic, Hearing Loss, Noise-Induced Trial in Seoul (Dexamethasone, Hyaluronic acid)
Recruiting
- Hearing Loss, Sudden
- +3 more
- Dexamethasone
- Hyaluronic acid
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 8, 2021
Diffuse Large B Cell Lymphoma (DLBCL) Trial in Denver, Nashville (bbT369)
Recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
- bbT369
-
Denver, Colorado
- +1 more
Feb 10, 2022
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Insomnia, Chronic Pain Trial in Grand Rapids (Cognitive Behavioral Therapy for Insomnia (CBT-I), Interdisciplinary Pain
Completed
- Insomnia
- Chronic Pain
- Cognitive Behavioral Therapy for Insomnia (CBT-I)
- Interdisciplinary Pain Rehabilitation Program (IPRP)
-
Grand Rapids, MichiganMary Free Bed Rehabilitation Hospital
Aug 29, 2021
Breast Cancer Trial in Shanghai (Letrozole, Pyrotinib, Dalpiciclib(SHR6390))
Recruiting
- Breast Cancer
- Letrozole
- +3 more
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Jan 21, 2022
Thrombectomy, Tandem Occlusion, Stroke Trial in Lishui (device, procedure, drug)
Recruiting
- Thrombectomy
- +2 more
- Carotid Stenting
- +3 more
-
Lishui, Zhejiang, ChinaLishui Municipal Hospital
Jun 13, 2023
Chronic Kidney Diseases Trial in Seoul (dual anti-platelet therapy at least 6 months, dual anti-platelet therapy 3months or
Recruiting
- Chronic Kidney Diseases
- dual anti-platelet therapy at least 6 months
- dual anti-platelet therapy 3months or less
-
Seoul, Korea, Republic ofDivision of Cardiology, Yonsei Cardiovascular Hospital, Yonsei U
Jul 28, 2021
Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy Trial in Toronto (Risperidone, Olanzapine)
Recruiting
- Schizophrenia and Related Disorders
- +3 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jul 20, 2022
Viral Hepatitis B, C and HIV Among Drug Users in
Recruiting
- Hepatitis C
- +4 more
-
Limoges, Haute Vienne, FranceChu Limoges
May 3, 2022
Insomnia Trial in Ann Arbor (Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM), Sleep Hygiene Education (SHE-TM))
Not yet recruiting
- Insomnia
- Cognitive Behavioral Therapy for insomnia (CBTi-CB-TM)
- Sleep Hygiene Education (SHE-TM)
-
Ann Arbor, MichiganUniversity of Michigan
Apr 3, 2023
Health-related Quality of Life After Switching COPD Patients
Recruiting
- Pulmonary Disease, Chronic Obstructive
- Spiriva® Respimat®
- +2 more
-
Liestal, SwitzerlandCantonal Hosp. Baselland,Univ.Med.Dept,Liestal
Jan 9, 2023
Opioid Use, Opioid Use Disorder, Cocaine Use Trial in Cerritos, Baltimore (DynamiCare Health, Methadone Treatment-As-Usual)
Not yet recruiting
- Opioid Use
- +3 more
- DynamiCare Health
- Methadone Treatment-As-Usual
-
Cerritos, California
- +3 more
Mar 9, 2023
MDD Trial in United States (NeuroStar TMS)
Completed
- Major Depressive Disorder
- NeuroStar TMS
-
Chicago, Illinois
- +5 more
Sep 30, 2021
Chronic Kidney Disease (CKD) Trial in Jakarta (Recombinant Human Erythropoietin Alpha)
Completed
- Chronic Kidney Disease (CKD)
- Recombinant Human Erythropoietin Alpha
-
Jakarta, IndonesiaGatot Soebroto Army Hospital
Jul 12, 2022
Insomnia Trial in Baltimore (behavioral, device, drug, other)
Not yet recruiting
- Insomnia
- Baseline surveys, Cognitive testing and EMAs
- +3 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore
Jun 9, 2023
Intracranial Atherosclerosis, Stroke Trial in Beijing (procedure, drug, behavioral)
Recruiting
- Intracranial Atherosclerosis
- Stroke
- Drug Eluting Stent implantation
- +3 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital
Aug 24, 2021
Atrial Fibrillation Trial in Seoul (NOAC monotherapy, Dual therapy with apixaban and clopidogrel)
Recruiting
- Atrial Fibrillation
- NOAC monotherapy
- Dual therapy with apixaban and clopidogrel
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital, Yonsei University Health Syst
Sep 10, 2021